Ignelzi Troy A.'s Form 4 filing
Rapport Therapeutics, Inc. (RAPP) · filed Mar 13, 2025
- Accession no.
- 0000950170-25-038878
- Filed
- Mar 13, 2025
- Trade date
- Mar 12-13, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $101.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ignelzi Troy A.CIK 0001579829 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | Common Stock | PPurchaseAcquired | +9,900 | $10.10 | +$99,990 | 9,900 | Direct | |
| Mar 13, 2025 | Common Stock | PPurchaseAcquired | +100 | $9.98 | +$998 | 10,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.